Delaware
|
06-1059331
|
|
(State
or other jurisdiction
|
(I.R.S.
Employer
|
|
of
incorporation or organization)
|
Identification
No.)
|
|
Page
No.
|
FINANCIAL
INFORMATION
|
|||
Item
1.
|
Financial
Statements
|
||
Consolidated
Income Statements
|
|||
Consolidated
Balance Sheets
|
|||
Consolidated
Statements of Comprehensive
|
|||
Income
and Changes in Shareholders' Equity
|
|||
Consolidated
Statements of Cash Flows
|
|||
Notes
to the Financial Statements
|
|||
Item
2.
|
Management's
Discussion and Analysis
|
||
of
Financial Condition and Results of Operations
|
|||
Item
3.
|
Quantitative
and Qualitative Disclosures About
|
||
Market
Risk
|
|||
Item
4.
|
Controls
and Procedures
|
||
OTHER
INFORMATION
|
|||
Item
1.
|
Legal
Proceedings
|
||
Item
2.
|
Unregistered
Sales of Equity Securities and
|
||
Use
of Proceeds
|
|||
Item
6.
|
Exhibits
|
||
Part I. FINANCIAL INFORMATION | |||||||||||||
Item 1. Financial Statements | |||||||||||||
CONSOLIDATED
STATEMENTS OF INCOME
|
|||||||||||||
(In
millions, except per share amounts)
|
|||||||||||||
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||
September
30,
|
September
30,
|
||||||||||||
2005
|
2004
|
2005
|
2004
|
||||||||||
REVENUES
|
|||||||||||||
Premiums
and fees
|
$
|
3,381
|
$
|
3,618
|
$
|
10,151
|
$
|
10,754
|
|||||
Net
investment income
|
334
|
340
|
995
|
1,298
|
|||||||||
Other
revenues
|
298
|
510
|
1,300
|
1,335
|
|||||||||
Realized
investment gains
|
9
|
11
|
28
|
447
|
|||||||||
Total revenues
|
4,022
|
4,479
|
12,474
|
13,834
|
|||||||||
BENEFITS
AND EXPENSES
|
|||||||||||||
Health
Care medical claims expense
|
1,579
|
1,671
|
4,633
|
5,044
|
|||||||||
Other
benefit expenses
|
786
|
946
|
2,481
|
3,022
|
|||||||||
Other
operating expenses
|
1,274
|
1,367
|
3,875
|
4,202
|
|||||||||
Total benefits and expenses
|
3,639
|
3,984
|
10,989
|
12,268
|
|||||||||
INCOME
FROM CONTINUING OPERATIONS
|
|||||||||||||
BEFORE INCOME TAXES (BENEFITS)
|
383
|
495
|
1,485
|
1,566
|
|||||||||
Income
taxes (benefits):
|
|||||||||||||
Current
|
(58
|
)
|
58
|
169
|
649
|
||||||||
Deferred
|
182
|
129
|
250
|
(102
|
)
|
||||||||
Total taxes
|
124
|
187
|
419
|
547
|
|||||||||
INCOME
FROM CONTINUING OPERATIONS
|
259
|
308
|
1,066
|
1,019
|
|||||||||
INCOME
FROM DISCONTINUED OPERATIONS
|
-
|
-
|
349
|
-
|
|||||||||
INCOME
BEFORE CUMULATIVE EFFECT
|
|||||||||||||
OF ACCOUNTING CHANGE
|
259
|
308
|
1,415
|
1,019
|
|||||||||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE,
|
|||||||||||||
NET OF TAXES
|
-
|
-
|
-
|
(139
|
)
|
||||||||
NET
INCOME
|
$
|
259
|
$
|
308
|
$
|
1,415
|
$
|
880
|
|||||
EARNINGS
PER SHARE - BASIC
|
|||||||||||||
INCOME
FROM CONTINUING OPERATIONS
|
$
|
2.04
|
$
|
2.28
|
$
|
8.27
|
$
|
7.39
|
|||||
INCOME
FROM DISCONTINUED OPERATIONS
|
-
|
-
|
2.71
|
-
|
|||||||||
INCOME
BEFORE CUMULATIVE EFFECT
|
|||||||||||||
OF ACCOUNTING CHANGE
|
2.04
|
2.28
|
10.98
|
7.39
|
|||||||||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE,
|
|||||||||||||
NET OF TAXES
|
-
|
-
|
-
|
(1.01
|
)
|
||||||||
NET
INCOME
|
$
|
2.04
|
$
|
2.28
|
$
|
10.98
|
$
|
6.38
|
|||||
EARNINGS
PER SHARE - DILUTED
|
|||||||||||||
INCOME
FROM CONTINUING OPERATIONS
|
$
|
2.00
|
$
|
2.26
|
$
|
8.12
|
$
|
7.32
|
|||||
INCOME
FROM DISCONTINUED OPERATIONS
|
-
|
-
|
2.66
|
-
|
|||||||||
INCOME
BEFORE CUMULATIVE EFFECT
|
|||||||||||||
OF
ACCOUNTING CHANGE
|
2.00
|
2.26
|
10.78
|
7.32
|
|||||||||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE,
|
|||||||||||||
NET OF TAXES
|
-
|
-
|
-
|
(1.00
|
)
|
||||||||
NET
INCOME
|
$
|
2.00
|
$
|
2.26
|
$
|
10.78
|
$
|
6.32
|
|||||
DIVIDENDS
DECLARED PER SHARE
|
$
|
0.025
|
$
|
0.025
|
$
|
0.075
|
$
|
0.380
|
|||||
The
accompanying Notes to the Financial Statements are an integral
part of
these statements.
|
|||||||||||||
CONSOLIDATED
BALANCE SHEETS
|
|||||||||||||
(In
millions, except per share amounts)
|
|||||||||||||
As
of
|
As
of
|
||||||||||||
September
30,
|
December
31,
|
||||||||||||
2005
|
2004
|
||||||||||||
ASSETS
|
|||||||||||||
Investments:
|
|||||||||||||
Fixed maturities, at fair value (amortized cost, $14,359;
$14,758)
|
$
|
15,554
|
$
|
16,081
|
|||||||||
Equity securities, at fair value (cost, $62; $65)
|
74
|
88
|
|||||||||||
Mortgage loans
|
3,919
|
3,529
|
|||||||||||
Policy loans
|
1,341
|
1,594
|
|||||||||||
Real estate
|
78
|
78
|
|||||||||||
Other long-term investments
|
508
|
478
|
|||||||||||
Short-term investments
|
540
|
71
|
|||||||||||
Total investments
|
22,014
|
21,919
|
|||||||||||
Cash
and cash equivalents
|
1,251
|
2,519
|
|||||||||||
Accrued
investment income
|
285
|
285
|
|||||||||||
Premiums,
accounts and notes receivable
|
1,667
|
1,628
|
|||||||||||
Reinsurance
recoverables
|
7,382
|
14,595
|
|||||||||||
Deferred
policy acquisition costs
|
588
|
544
|
|||||||||||
Property
and equipment
|
660
|
777
|
|||||||||||
Deferred
income taxes
|
1,238
|
1,383
|
|||||||||||
Goodwill
|
1,620
|
1,620
|
|||||||||||
Other
assets, including other intangibles
|
330
|
312
|
|||||||||||
Separate
account assets
|
8,862
|
35,477
|
|||||||||||
Total assets
|
$
|
45,897
|
$
|
81,059
|
|||||||||
LIABILITIES
|
|||||||||||||
Contractholder
deposit funds
|
$
|
10,359
|
$
|
17,839
|
|||||||||
Future
policy benefits
|
8,415
|
8,428
|
|||||||||||
Unpaid
claims and claim expenses
|
4,365
|
4,311
|
|||||||||||
Health
Care medical claims payable
|
1,168
|
1,594
|
|||||||||||
Unearned
premiums
|
357
|
343
|
|||||||||||
Total insurance and contractholder liabilities
|
24,664
|
32,515
|
|||||||||||
Accounts
payable, accrued expenses and other liabilities
|
5,210
|
6,359
|
|||||||||||
Short-term
debt
|
100
|
-
|
|||||||||||
Long-term
debt
|
1,338
|
1,438
|
|||||||||||
Nonrecourse
obligations
|
65
|
67
|
|||||||||||
Separate
account liabilities
|
8,862
|
35,477
|
|||||||||||
Total liabilities
|
40,239
|
75,856
|
|||||||||||
|
|
||||||||||||
CONTINGENCIES
- NOTE 13
|
|||||||||||||
SHAREHOLDERS'
EQUITY
|
|||||||||||||
Common
stock (par value per share, $0.25; shares issued, 160;
160)
|
40
|
40
|
|||||||||||
Additional
paid-in capital
|
2,262
|
2,360
|
|||||||||||
Net
unrealized appreciation, fixed maturities
|
$
|
245
|
$
|
392
|
|||||||||
Net
unrealized appreciation, equity securities
|
10
|
15
|
|||||||||||
Net
unrealized depreciation, derivatives
|
(14
|
)
|
(16
|
)
|
|||||||||
Net
translation of foreign currencies
|
(3
|
)
|
2
|
||||||||||
Minimum
pension liability adjustment
|
(759
|
)
|
(729
|
)
|
|||||||||
Accumulated other comprehensive loss
|
(521
|
)
|
(336
|
)
|
|||||||||
Retained
earnings
|
5,084
|
3,679
|
|||||||||||
Less
treasury stock, at cost
|
(1,207
|
)
|
(540
|
)
|
|||||||||
Total shareholders' equity
|
5,658
|
5,203
|
|||||||||||
Total liabilities and shareholders' equity
|
$
|
45,897
|
$
|
81,059
|
|||||||||
SHAREHOLDERS'
EQUITY PER SHARE
|
$
|
44.98
|
$
|
39.41
|
|||||||||
The
accompanying Notes to the Financial Statements are an integral
part of
these statements.
|
CONSOLIDATED
STATEMENTS OF COMPREHENSIVE INCOME AND CHANGES
IN
|
|||||||||||||
SHAREHOLDERS'
EQUITY
|
|||||||||||||
(In
millions)
|
|||||||||||||
Three
Months Ended September 30,
|
2005
|
2004
|
|||||||||||
Compre-
hensive
Income
|
|
Share-
holders'
Equity
|
Compre-
hensive
Income
|
|
Share-
holders'
Equity
|
||||||||
Common
stock
|
$
|
40
|
$
|
69
|
|||||||||
Additional
paid-in capital, July 1
|
2,285
|
3,727
|
|||||||||||
Effect of issuance of stock for employee benefits plans
|
(23
|
)
|
17
|
||||||||||
Additional
paid-in capital, September 30
|
2,262
|
3,744
|
|||||||||||
Accumulated
other comprehensive loss, July 1
|
(390
|
)
|
(597
|
)
|
|||||||||
Net unrealized appreciation (depreciation), fixed
maturities
|
$
|
(128
|
)
|
(128
|
)
|
$
|
197
|
197
|
|||||
Net unrealized appreciation (depreciation), equity
securities
|
2
|
2
|
(6
|
)
|
(6
|
)
|
|||||||
Net unrealized appreciation (depreciation) on securities
|
(126
|
)
|
191
|
||||||||||
Net unrealized appreciation (depreciation), derivatives
|
(5
|
)
|
(5
|
)
|
3
|
3
|
|||||||
Net translation of foreign currencies
|
-
|
-
|
3
|
3
|
|||||||||
Minimum pension liability adjustment
|
-
|
-
|
21
|
21
|
|||||||||
Other comprehensive income (loss)
|
(131
|
)
|
218
|
||||||||||
Accumulated
other comprehensive loss, September 30
|
(521
|
)
|
(379
|
)
|
|||||||||
Retained
earnings, July 1
|
4,829
|
10,024
|
|||||||||||
Net income
|
259
|
259
|
308
|
308
|
|||||||||
Common dividends declared
|
(4
|
)
|
(4
|
)
|
|||||||||
Retained
earnings, September 30
|
5,084
|
10,328
|
|||||||||||
Treasury
stock, July 1
|
(885
|
)
|
(8,856
|
)
|
|||||||||
Repurchase of common stock
|
(466
|
)
|
(210
|
)
|
|||||||||
Other, primarily issuance of treasury stock for employee
benefit
plans
|
144
|
8
|
|||||||||||
Treasury
stock, September 30
|
(1,207
|
)
|
(9,058
|
)
|
|||||||||
TOTAL
COMPREHENSIVE INCOME (LOSS) AND
SHAREHOLDERS'
EQUITY
|
$
|
128
|
$
|
5,658
|
$
|
526
|
$
|
4,704
|
|||||
Nine Months Ended September 30, | |||||||||||||
Common
stock
|
$
|
40
|
$
|
69
|
|||||||||
Additional
paid-in capital, January 1
|
2,360
|
3,647
|
|||||||||||
Effects of issuance of stock for employee benefits plans
|
(98
|
)
|
97
|
||||||||||
Additional
paid-in capital, September 30
|
2,262
|
3,744
|
|||||||||||
Accumulated
other comprehensive loss, January 1
|
(336
|
)
|
(54
|
)
|
|||||||||
Net unrealized depreciation, fixed maturities
|
$
|
(147
|
)
|
(147
|
)
|
$
|
(195
|
)
|
(195
|
)
|
|||
Net unrealized depreciation, equity securities
|
(5
|
)
|
(5
|
)
|
(9
|
)
|
(9
|
)
|
|||||
Net unrealized depreciation on securities
|
(152
|
)
|
(204
|
)
|
|||||||||
Net unrealized appreciation, derivatives
|
2
|
2
|
9
|
9
|
|||||||||
Net translation of foreign currencies
|
(5
|
)
|
(5
|
)
|
1
|
1
|
|||||||
Minimum pension liability adjustment
|
(30
|
)
|
(30
|
)
|
(131
|
)
|
(131
|
)
|
|||||
Other comprehensive loss
|
(185
|
)
|
(325
|
)
|
|||||||||
Accumulated
other comprehensive loss, September 30
|
(521
|
)
|
(379
|
)
|
|||||||||
Retained
earnings, January 1
|
3,679
|
9,502
|
|||||||||||
Net income
|
1,415
|
1,415
|
880
|
880
|
|||||||||
Common dividends declared
|
(10
|
)
|
(54
|
)
|
|||||||||
Retained
earnings, September 30
|
5,084
|
10,328
|
|||||||||||
Treasury
stock, January 1
|
(540
|
)
|
(8,557
|
)
|
|||||||||
Repurchase of common stock
|
(1,055
|
)
|
(494
|
)
|
|||||||||
Other, primarily issuance of treasury stock for employee
benefit
plans
|
388
|
(7
|
)
|
||||||||||
Treasury
stock, September 30
|
(1,207
|
)
|
(9,058
|
)
|
|||||||||
TOTAL
COMPREHENSIVE INCOME AND
SHAREHOLDERS'
EQUITY
|
$
|
1,230
|
$
|
5,658
|
$
|
555
|
$
|
4,704
|
|||||
The
accompanying Notes to the Financial Statements are an integral
part of
these statements.
|
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|||||||
Nine
Months Ended September 30,
|
|||||||
2005
|
2004
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
|||||||
Income from continuing operations
|
$
|
1,066
|
$
|
1,019
|
|||
Adjustments to reconcile income from continuing
|
|||||||
operations to net cash provided by operating activities:
|
|||||||
Insurance liabilities
|
(447
|
)
|
(601
|
)
|
|||
Reinsurance recoverables
|
1
|
127
|
|||||
Deferred policy acquisition costs
|
(45
|
)
|
(72
|
)
|
|||
Premiums, accounts and notes receivable
|
159
|
309
|
|||||
Accounts payable, accrued expenses and other liabilities
|
(401
|
)
|
(180
|
)
|
|||
Current income taxes
|
(72
|
)
|
98
|
||||
Deferred income taxes
|
250
|
(102
|
)
|
||||
Realized investment (gains)
|
(28
|
)
|
(447
|
)
|
|||
Depreciation and amortization
|
170
|
174
|
|||||
Gains on sales of businesses
|
(374
|
)
|
(239
|
)
|
|||
Proceeds from sales and maturities of securities supporting
|
|||||||
experience-rated pension policyholder contracts,
|
|||||||
net of purchases
|
-
|
1,039
|
|||||
Other, net
|
(26
|
)
|
79
|
||||
Net cash provided by operating activities
|
253
|
1,204
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
|||||||
Proceeds from investments sold:
|
|||||||
Fixed maturities
|
2,110
|
2,245
|
|||||
Equity securities
|
10
|
62
|
|||||
Mortgage loans
|
262
|
64
|
|||||
Other (primarily short-term investments)
|
5,608
|
5,803
|
|||||
Investment maturities and repayments:
|
|||||||
Fixed maturities
|
707
|
655
|
|||||
Mortgage loans
|
205
|
662
|
|||||
Investments purchased:
|
|||||||
Fixed maturities
|
(2,377
|
)
|
(3,624
|
)
|
|||
Equity securities
|
(9
|
)
|
(14
|
)
|
|||
Mortgage loans
|
(858
|
)
|
(668
|
)
|
|||
Other (primarily short-term investments)
|
(5,885
|
)
|
(5,575
|
)
|
|||
Proceeds from sale of businesses
|
-
|
2,103
|
|||||
Property and equipment, net
|
(32
|
)
|
(32
|
)
|
|||
Other, net
|
(18
|
)
|
(24
|
)
|
|||
Net cash provided by (used in) investing activities
|
(277
|
)
|
1,657
|
||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
|||||||
Deposits and interest credited to contractholder deposit
funds
|
464
|
2,235
|
|||||
Withdrawals and benefit payments from contractholder deposit
funds
|
(748
|
)
|
(2,908
|
)
|
|||
Change in cash overdraft position
|
(219
|
)
|
(23
|
)
|
|||
Repayment of long-term debt
|
-
|
(76
|
)
|
||||
Repurchase common stock
|
(1,034
|
)
|
(526
|
)
|
|||
Issuance of common stock
|
301
|
24
|
|||||
Common dividends paid
|
(10
|
)
|
(54
|
)
|
|||
Net cash used in financing activities
|
(1,246
|
)
|
(1,328
|
)
|
|||
Effect of foreign currency rates on cash
|
2
|
-
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(1,268
|
)
|
1,533
|
||||
Cash
and cash equivalents, beginning of period
|
2,519
|
1,392
|
|||||
Cash
and cash equivalents, end of period
|
$
|
1,251
|
$
|
2,925
|
|||
Supplemental
Disclosure of Cash Information:
|
|||||||
Income taxes paid, net
|
$
|
218
|
$
|
543
|
|||
Interest paid
|
$
|
75
|
$
|
79
|
|||
The
accompanying Notes to the Financial Statements are an integral
part of
these statements.
|
(In
millions, except per share amounts)
|
Three
Months
Ended
September
30, 2004
|
Nine
Months
Ended
September
30, 2004
|
|||||
Net
income, prior to implementation
|
|
$
|
312
|
|
$
|
878
|
|
Compensation
expense for stock options, net of taxes, prior to
implementation
|
|
|
8
|
|
|
35
|
|
Compensation
expense for stock options, net of taxes, under SFAS 123R
|
|
|
(12
|
)
|
|
(33
|
)
|
Net
income under SFAS 123R
|
|
$
|
308
|
|
$
|
880
|
|
Net
income per share:
|
|
|
|
|
|
|
|
Basic
- prior to implementation
|
|
$
|
2.31
|
|
$
|
6.37
|
|
Basic
- as restated
|
|
$
|
2.28
|
|
$
|
6.38
|
|
Diluted
- prior to implementation
|
|
$
|
2.29
|
|
$
|
6.30
|
|
Diluted
- as restated
|
$
|
2.26
|
$
|
6.32
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions)
|
2005
|
2004
|
2005
|
2004
|
|||||||||
Compensation
expense
|
$
|
10
|
$
|
20
|
$
|
24
|
$
|
54
|
|||||
Tax
benefits
|
$
|
4
|
$
|
6
|
$
|
9
|
$
|
18
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(Options
in thousands)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Options
granted
|
|
|
7
|
|
|
7
|
|
|
825
|
|
|
3,166
|
|
Weighted
average fair value of
options granted
|
$
|
41.33
|
$
|
21.85
|
$
|
34.08
|
$
|
19.80
|
As
of
|
||||
September
30,
2005
|
December
31,
2004
|
|||
Dividend
yield
|
0.1%
|
0.2%
|
||
Expected
volatility
|
35.0%
|
47.6%
|
||
Risk-free
interest rate
|
3.9%
|
2.2%
|
||
Expected
option life
|
5.25
years
|
3.3
years
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||
(Grants
in thousands)
|
2005
|
2004
|
2005
|
2004
|
Restricted
stock granted
|
19
|
3
|
331
|
421
|
Weighted
average fair value
|
$104.90
|
$61.64
|
$92.45
|
$56.98
|
·
|
$287
million resulting from capital losses realized in connection
with the
divestiture of the property and casualty insurance operations
in 1999,
which is included in income from discontinued operations;
and
|
·
|
$150
million resulting primarily from the release of tax reserves
and valuation
allowances of which:
|
·
|
$88
million is reported as income from continuing operations;
and
|
·
|
$62
million relates to the divestiture of CIGNA's Brazilian health
care
business, which is included in income from discontinued
operations.
|
(In
millions)
|
Pre-Tax
|
After-Tax
|
|||||
Three
Months Ended September 30,
|
|||||||
2005
|
|||||||
Accelerated
deferred gain amortization
|
$
|
10
|
$
|
2
|
|||
Normal
deferred gain amortization
|
$
|
3
|
$
|
2
|
|||
2004
|
|||||||
Accelerated
deferred gain amortization
|
$
|
122
|
$
|
79
|
|||
Normal
deferred gain amortization
|
$
|
28
|
$
|
18
|
|||
Nine
Months Ended September 30,
|
|||||||
2005
|
|||||||
Accelerated
deferred gain amortization
|
$
|
315
|
$
|
200
|
|||
Normal
deferred gain amortization
|
$
|
21
|
$
|
14
|
|||
2004
|
|||||||
Accelerated
deferred gain amortization
|
$
|
126
|
$
|
82
|
|||
Normal
deferred gain amortization
|
$
|
57
|
$
|
37
|
FINANCIAL SUMMARY
(In
millions)
|
Nine
Months
Ended
September
30, 2005
|
|||
Income
tax benefits:
|
||||
Property
and Casualty insurance business
|
$
|
287
|
||
Brazilian
Health Care operations
|
62
|
|||
Income
from discontinued operations
|
$
|
349
|
(In
millions)
|
Health
Care
|
Corporate
|
Total
|
|||||||
First
quarter 2005 charge
|
$
|
22
|
$
|
29
|
$
|
51
|
||||
First
quarter 2005 payments
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
||||
Balance
as of March 31, 2005
|
21
|
27
|
48
|
|||||||
Second
quarter 2005 payments
|
(5
|
)
|
(6
|
)
|
(11
|
)
|
||||
Balance
as of June 30, 2005
|
16
|
21
|
37
|
|||||||
Third
quarter 2005 payments
|
(4
|
)
|
(5
|
)
|
(9
|
)
|
||||
Balance
as of September 30, 2005
|
$
|
12
|
$
|
16
|
$
|
28
|
(In
millions)
|
Health
Care/
Disability
and Life*
|
Corporate
|
Total
|
|||||||
Balance
as of December 31, 2004:
|
||||||||||
Severance
|
$
|
11
|
$
|
9
|
$
|
20
|
||||
Real
estate
|
8
|
1
|
9
|
|||||||
19
|
10
|
29
|
||||||||
First
quarter 2005 payments:
|
||||||||||
Severance
|
(6
|
)
|
(6
|
)
|
(12
|
)
|
||||
Real
estate
|
(1
|
)
|
-
|
(1
|
)
|
|||||
Balance
as of March 31, 2005
|
12
|
4
|
16
|
|||||||
Second
quarter 2005 payments:
|
||||||||||
Severance
|
(4
|
)
|
(2
|
)
|
(6
|
)
|
||||
Real
estate
|
(1
|
)
|
(1
|
)
|
(2
|
)
|
||||
Balance
as of June 30, 2005
|
7
|
1
|
8
|
|||||||
Third
quarter 2005 payments:
|
||||||||||
Severance
|
(1
|
)
|
-
|
(1
|
)
|
|||||
Real
estate
|
(1
|
)
|
-
|
(1
|
)
|
|||||
Balance
as of September 30, 2005
|
$
|
5
|
$
|
1
|
$
|
6
|
·
|
The
reserves represent estimates of the present value of net
amounts expected
to be paid, less the present value of net future premiums.
Included in net
amounts expected to be paid is the excess of the guaranteed
death benefits
over the values of the contractholders’ accounts (based on underlying
equity and bond mutual fund
investments).
|
·
|
The
reserves include an estimate for partial surrenders that
essentially lock
in the death benefit for a particular policy based on annual
election
rates that vary from 0-20% depending on the net amount at
risk for each
policy and whether surrender charges
apply.
|
·
|
The
mean investment performance assumption is 5% considering
CIGNA's program
to reduce equity market exposures using futures and forward
contracts.
|
·
|
The
volatility assumption is 15-30%, varying by equity fund type;
3-8%,
varying by bond fund type; and 1% for money market
funds.
|
·
|
The
discount rate is 5.75%.
|
·
|
The
mortality assumption is 70-75% of the 1994 Group Annuity
Mortality table,
with 1% annual improvement beginning January 1,
2000.
|
·
|
The
lapse rate assumption is 0-15%, depending on contract type,
policy
duration and the ratio of the net amount at risk to account
value.
|
·
|
$105
million for minimum funding requirements for the domestic
pension plan and
for voluntary contributions to the international pension
plans;
and
|
·
|
$440
million for voluntary contributions to the domestic pension
plan, which
represent
an acceleration of expected payments for minimum funding
requirements in
2006 and 2007.
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Service
cost
|
$
|
18
|
$
|
18
|
$
|
54
|
$
|
56
|
|||||
Interest
cost
|
56
|
55
|
166
|
165
|
|||||||||
Expected
return on plan assets
|
(46
|
)
|
(47
|
)
|
(136
|
)
|
(143
|
)
|
|||||
Amortization
of:
Net
loss from past
experience
|
35
|
28
|
105
|
76
|
|||||||||
Prior
service cost
|
—
|
(1
|
)
|
(1
|
)
|
(1
|
)
|
||||||
Net
pension cost
|
$
|
63
|
$
|
53
|
$
|
188
|
$
|
153
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions)
|
2005
|
2004
|
2005
|
2004
|
|||||||||
Service
cost
|
$
|
1
|
$
|
1
|
$
|
2
|
$
|
2
|
|||||
Interest
cost
|
7
|
7
|
20
|
24
|
|||||||||
Expected
return on plan assets
|
(1
|
)
|
(1
|
)
|
(2
|
)
|
(2
|
)
|
|||||
Amortization
of:
|
|||||||||||||
Net
gain from past experience
|
—
|
—
|
(1
|
)
|
—
|
||||||||
Prior
service cost
|
(4
|
)
|
(4
|
)
|
(12
|
)
|
(12
|
)
|
|||||
Net
other postretirement benefit
cost
|
$
|
3
|
$
|
3
|
$
|
7
|
$
|
12
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Fixed
maturities
|
$
|
10
|
$
|
3
|
$
|
25
|
$
|
119
|
|||||
Equity
securities
|
2
|
7
|
2
|
19
|
|||||||||
Mortgage
loans
|
-
|
(4
|
)
|
(2
|
)
|
215
|
|||||||
Real
estate
|
1
|
(1
|
)
|
-
|
51
|
||||||||
Derivatives
and other
|
(4
|
)
|
6
|
3
|
43
|
||||||||
Realized
investment gains,
before
income taxes
|
9
|
11
|
28
|
447
|
|||||||||
Less
income taxes
|
3
|
3
|
10
|
156
|
|||||||||
Net
realized investment gains
|
$
|
6
|
$
|
8
|
$
|
18
|
$
|
291
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||
(In
millions)
|
2005
|
2004
|
2005
|
2004
|
Proceeds
from sales
|
$635
|
$1,164
|
$2,120
|
$2,307
|
Gross
gains on sales
|
$11
|
$26
|
$33
|
$236
|
Gross
losses on sales
|
$(4)
|
$(7)
|
$(18)
|
$(41)
|
·
|
length
of time and severity of decline;
|
· | financial health and specific near term prospects of the issuer; and |
· | changes in the regulatory, economic or general market environment of the issuer’s industry or geographic region. |
|
|
|
||||||||
(In millions)
|
Fair
Value
|
|
Amortized
Cost
|
|
Unrealized
Depreciation
|
|||||
Fixed
maturities:
|
||||||||||
One
year or less:
|
||||||||||
Investment
grade
|
$
|
3,197
|
$
|
3,250
|
$
|
(53
|
)
|
|||
Below
investment grade
|
$
|
180
|
$
|
185
|
$
|
(5
|
)
|
|||
More
than one year:
|
||||||||||
Investment
grade
|
$
|
615
|
$
|
638
|
$
|
(23
|
)
|
|||
Below
investment grade
|
$
|
28
|
$
|
29
|
$
|
(1
|
)
|
|||
Equity
securities:
|
||||||||||
Greater
than one year
|
$
|
9
|
$
|
10
|
$
|
(1
|
)
|
(In millions)
|
As
of
September
30, 2005
|
|||
Fixed
maturities
|
$
|
91
|
||
Mortgage
loans
|
360
|
|||
Real
estate joint ventures
|
45
|
|||
Investments
in partnerships secured by real estate
|
109
|
|||
Investments
in partnerships secured by securities
|
196
|
|||
Total
|
$
|
801
|
·
|
amounts
required to adjust future policy benefits for certain annuities;
and
|
·
|
amounts
required to adjust other liabilities after the initial reclassification
of
unrealized appreciation under a modified coinsurance
arrangement.
|
(In
millions)
|
Pre-Tax
|
Tax
(Expense)
Benefit
|
After-Tax
|
|||||||
Three
Months Ended September 30,
|
||||||||||
2005
|
||||||||||
Net
unrealized depreciation, securities:
|
||||||||||
Unrealized
depreciation on securities held
|
$
|
(183
|
)
|
$
|
64
|
$
|
(119
|
)
|
||
Gains
realized on securities
|
(12
|
)
|
5
|
(7
|
)
|
|||||
Net
unrealized depreciation, securities
|
$
|
(195
|
)
|
$
|
69
|
$
|
(126
|
)
|
||
Net
unrealized depreciation, derivatives
|
$
|
(9
|
)
|
$
|
4
|
$
|
(5
|
)
|
||
Minimum
pension liability adjustment
|
$
|
1
|
$
|
(1
|
)
|
$
|
-
|
|||
2004
|
||||||||||
Net
unrealized appreciation,
securities:
|
||||||||||
Unrealized
appreciation on securities held
|
$
|
303
|
$
|
(106
|
)
|
$
|
197
|
|||
Gains
realized on securities
|
(10
|
)
|
4
|
(6
|
)
|
|||||
Net
unrealized appreciation, securities
|
$
|
293
|
$
|
(102
|
)
|
$
|
191
|
|||
Net
unrealized appreciation, derivatives
|
$
|
6
|
$
|
(3
|
)
|
$
|
3
|
|||
Net
translation of foreign currencies
|
$
|
5
|
$
|
(2
|
)
|
$
|
3
|
|||
Minimum
pension liability adjustment
|
$
|
32
|
$
|
(11
|
)
|
$
|
21
|
|||
Nine
months ended September 30,
|
||||||||||
2005
|
||||||||||
Net
unrealized depreciation, securities:
|
||||||||||
Unrealized
depreciation on securities held
|
$
|
(208
|
)
|
$
|
73
|
$
|
(135
|
)
|
||
Gains
realized on securities
|
(27
|
)
|
10
|
(17
|
)
|
|||||
Net
unrealized depreciation, securities
|
$
|
(235
|
)
|
$
|
83
|
$
|
(152
|
)
|
||
Net
unrealized appreciation, derivatives
|
$
|
3
|
$
|
(1
|
)
|
$
|
2
|
|||
Net
translation of foreign currencies
|
$
|
(6
|
)
|
$
|
1
|
$
|
(5
|
)
|
||
Minimum
pension liability adjustment
|
$
|
(45
|
)
|
$
|
15
|
$
|
(30
|
)
|
||
2004
|
||||||||||
Net
unrealized depreciation, securities:
|
||||||||||
Unrealized
appreciation on securities held
|
$
|
85
|
$
|
(34
|
)
|
$
|
51
|
|||
Gains
realized on securities
|
(138
|
)
|
49
|
(89
|
)
|
|||||
Reclassification
to other liabilities for modified coinsurance
|
(256
|
)
|
90
|
(166
|
)
|
|||||
Net
unrealized depreciation, securities
|
$
|
(309
|
)
|
$
|
105
|
$
|
(204
|
)
|
||
Net
unrealized appreciation, derivatives
|
$
|
14
|
$
|
(5
|
)
|
$
|
9
|
|||
Net
translation of foreign currencies
|
$
|
1
|
$
|
—
|
$
|
1
|
||||
Minimum
pension liability adjustment
|
$
|
(202
|
)
|
$
|
71
|
$
|
(131
|
)
|
(Dollars
in millions, except per share amounts)
|
Basic
|
|
Effect
of Dilution
|
|
Diluted
|
|||||
Three
Months Ended September 30,
|
||||||||||
2005
|
||||||||||
Income
from continuing operations
|
$
|
259
|
—
|
$ | 259 | |||||
Shares
(in
thousands):
|
||||||||||
Weighted
average
|
126,888
|
—
|
126,888 | |||||||
Options
and restricted stock grants
|
2,795
|
2,795 | ||||||||
Total
shares
|
126,888
|
2,795
|
129,683 | |||||||
EPS
|
$
|
2.04
|
$
|
(0.04
|
)
|
$ | 2.00 | |||
2004
|
||||||||||
Income
from continuing operations
|
$
|
308
|
$
|
—
|
$ | 308 | ||||
Shares
(in
thousands):
|
||||||||||
Weighted
average
|
134,910
|
— | 134,910 | |||||||
Options
and restricted stock grants
|
1,365 | 1,365 | ||||||||
Total
shares
|
134,910
|
1,365 | 136,275 | |||||||
EPS
|
$
|
2.28
|
$ | (0.02 | ) | $ | 2.26 | |||
Nine
Months Ended September 30,
|
||||||||||
2005
|
||||||||||
Income
from continuing operations
|
$
|
1,066
|
— | $ | 1,066 | |||||
Shares
(in
thousands):
|
||||||||||
Weighted
average
|
128,852
|
— | 128,852 | |||||||
Options
and restricted stock grants
|
2,386 | 2,386 | ||||||||
Total
shares
|
128,852
|
2,386 | 131,238 | |||||||
EPS
|
$
|
8.27
|
$ | (0.15 | ) | $ | 8.12 | |||
2004
|
||||||||||
Income
from continuing operations
|
$
|
1,019
|
— | $ | 1,019 | |||||
Shares
(in
thousands):
|
||||||||||
Weighted
average
|
137,893
|
— | 137,893 | |||||||
Options
and restricted stock grants
|
1,303 | 1,303 | ||||||||
Total
shares
|
137,893
|
1,303 | 139,196 | |||||||
EPS
|
$
|
7.39
|
$ | (0.07 | ) | $ | 7.32 |
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||
(In
millions)
|
2005
|
2004
|
2005
|
2004
|
Antidilutive
options
|
0.3
|
11.6
|
3.3
|
12.9
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions)
|
2005
|
2004
|
2005
|
2004
|
|||||||||
Premiums
and fees
|
|||||||||||||
Individual
life insurance and
annuity
business sold
|
$
|
66
|
$
|
72
|
$
|
202
|
$
|
219
|
|||||
Other
|
51
|
34
|
147
|
111
|
|||||||||
Total
|
$
|
117
|
$
|
106
|
$
|
349
|
$
|
330
|
|||||
Reinsurance
recoveries
|
|||||||||||||
Individual
life insurance and
annuity
business sold
|
$
|
93
|
$
|
75
|
$
|
233
|
$
|
224
|
|||||
Other
|
41
|
56
|
136
|
108
|
|||||||||
Total
|
$
|
134
|
$
|
131
|
$
|
369
|
$
|
332
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees and other revenues
|
|||||||||||||
Health
Care
|
$
|
2,783
|
$
|
3,038
|
$
|
8,352
|
$
|
9,025
|
|||||
Disability
and Life
|
557
|
532
|
1,667
|
1,578
|
|||||||||
International
|
316
|
252
|
920
|
748
|
|||||||||
Run-off
Retirement
|
13
|
194
|
338
|
522
|
|||||||||
Run-off
Reinsurance
|
(25
|
)
|
50
|
37
|
32
|
||||||||
Other
Operations
|
47
|
66
|
165
|
218
|
|||||||||
Corporate
|
(12
|
)
|
(4
|
)
|
(28
|
)
|
(34
|
)
|
|||||
Total
|
$
|
3,679
|
$
|
4,128
|
$
|
11,451
|
$
|
12,089
|
|||||
Income
(loss) from continuing operations
|
|||||||||||||
Health
Care
|
$
|
164
|
$
|
206
|
$
|
528
|
$
|
533
|
|||||
Disability
and Life
|
57
|
41
|
175
|
128
|
|||||||||
International
|
24
|
23
|
86
|
58
|
|||||||||
Run-off
Retirement
|
2
|
90
|
200
|
146
|
|||||||||
Run-off
Reinsurance
|
(3
|
)
|
(54
|
)
|
(29
|
)
|
(77
|
)
|
|||||
Other
Operations
|
25
|
23
|
95
|
59
|
|||||||||
Corporate
|
(16
|
)
|
(29
|
)
|
(7
|
)
|
(119
|
)
|
|||||
Segment
earnings
|
253
|
300
|
1,048
|
728
|
|||||||||
Realized
investment gains, net of taxes
|
6
|
8
|
18
|
291
|
|||||||||
Income
from continuing operations
|
$
|
259
|
$
|
308
|
$
|
1,066
|
$
|
1,019
|
·
|
These
liabilities represent estimates of the present value of net
amounts
expected to be paid, less the present value of net future
premiums
expected to be received. Included in net amounts expected
to be paid is
the excess of the expected value of the income benefits over
the values of
the annuitant’s accounts at the time of annuitization. The assets
associated with these contracts represent receivables in
connection with
reinsurance that CIGNA has purchased from third parties.
|
·
|
The
market return assumption is 8-12% varying by equity fund
type; 6-9%
varying by bond fund type; and 5-6% for money market
funds.
|
·
|
The
volatility assumption is 14-24%, varying by equity fund type;
6-7%,
varying by bond fund type; and 2-3% for money market
funds.
|
·
|
The
discount rate is 5.75%.
|
·
|
The
projected interest rate used to calculate the reinsured income
benefits at
the time of annuitization varies by economic scenario, reflects
interest
rates as of the valuation date, and has a long-term mean
rate of 5-6% and
a standard deviation of 12-13%.
|
·
|
The
mortality assumption is 75% of the 1994 Group Annuity Mortality
table,
with 1% annual improvement beginning January 1,
2000.
|
·
|
The
lapse rate assumption is 2-15%, depending on policy
duration.
|
·
|
The
annuity election rate assumption is that no more than 5%
of the policies
eligible to annuitize their variable annuity contracts will
do so each
year.
|
·
|
No
annuitants surrendered their accounts,
and
|
·
|
All
annuitants lived to elect their benefits;
and
|
·
|
All
annuitants elected to receive their benefit on the first
available date
(2005 through 2014); and
|
·
|
All
underlying mutual fund investment values remained at the
September 30,
2005 value of $3.3 billion, with no future
returns.
|
·
|
additional
mandated benefits or services that increase costs without
improving the
quality of care;
|
·
|
legislation
that would grant plan participants broader rights to sue
their health
plans;
|
·
|
changes
in ERISA regulations resulting in increased administrative
burdens and
costs;
|
·
|
additional
restrictions on the use of prescription drug formularies;
|
·
|
additional
privacy legislation and regulations that interfere with the
proper use of
medical information for research, coordination of medical
care and disease
and disability management;
|
·
|
additional
rules establishing the time periods for payment of health
care provider
claims that vary from state to state;
|
·
|
legislation
that would exempt independent physicians from antitrust laws;
and
|
·
|
changes
in federal laws, such as amendments to income tax laws, which
could affect
the taxation of employer provided benefits, and pension legislation,
which
could increase pension cost.
|
INDEX
|
|
Introduction
|
20 |
Overview
|
20 |
Consolidated
Results of Operations
|
21 |
Acquisitions
and Dispositions
|
24 |
Other
Matters
|
26 |
Health
Care
|
29 |
Disability
and Life
|
31 |
International
|
32 |
Run-off
Retirement
|
32 |
Run-off
Reinsurance
|
33 |
Other
Operations
|
35 |
Corporate
|
36 |
Discontinued
Operations
|
36 |
Liquidity
and Capital Resources
|
|
Investment
Assets
|
41 |
Market
Risk
|
41 |
Cautionary
Statement
|
43 |
·
|
cost
trends and inflation levels for medical and related
services;
|
·
|
patterns
of utilization of medical and other
services;
|
·
|
employment
levels;
|
·
|
the
tort liability system;
|
·
|
interest
rates and equity market returns;
|
·
|
regulations
and tax rules related to the provision and administration of employee
benefit plans; and
|
·
|
initiatives
to increase health care regulation.
|
·
|
competitiveness
of CIGNA's product design and service
quality;
|
·
|
the
absolute level of and trends in benefit
costs;
|
·
|
the
volume of customers served and the mix of products and services
purchased
by those customers;
|
·
|
the
ability to price products and services competitively at levels
that
appropriately account for underlying cost inflation and utilization
patterns; and
|
·
|
the
relationship between administrative costs and
revenues.
|
FINANCIAL
SUMMARY
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
3,381
|
$
|
3,618
|
$
|
10,151
|
$
|
10,754
|
|||||
Net
investment income
|
334
|
340
|
995
|
1,298
|
|||||||||
Other
revenues
|
298
|
510
|
1,300
|
1,335
|
|||||||||
Realized
investment gains
|
9
|
11
|
28
|
447
|
|||||||||
Total
revenues
|
4,022
|
4,479
|
12,474
|
13,834
|
|||||||||
Benefits
and expenses
|
3,639
|
3,984
|
10,989
|
12,268
|
|||||||||
Income
from continuing
operations
before taxes
|
383
|
495
|
1,485
|
1,566
|
|||||||||
Income
taxes
|
124
|
187
|
419
|
547
|
|||||||||
Income
from continuing
operations
|
259
|
308
|
1,066
|
1,019
|
|||||||||
Income
from discontinued
operations
|
—
|
—
|
349
|
—
|
|||||||||
Income
before cumulative
effect
of accounting
change
|
259
|
308
|
1,415
|
1,019
|
|||||||||
Cumulative
effect of
accounting
change, net
of
taxes
(See Note 2 to the
Financial
Statements)
|
—
|
—
|
—
|
(139
|
)
|
||||||||
Net
income
|
$
|
259
|
$
|
308
|
$
|
1,415
|
$
|
880
|
|||||
Realized
investment gains,
net
of taxes
|
$
|
6
|
$
|
8
|
$
|
18
|
$
|
291
|
·
|
lower
losses in the Run-off Reinsurance segment and Corporate;
|
·
|
higher
earnings in ongoing operating businesses;
and
|
·
|
lower
results in the Run-off Retirement
segment.
|
·
|
$287
million resulting from capital losses realized in connection with
the
divestiture of the property and casualty insurance operations in
1999,
which is included in income from discontinued operations;
and
|
·
|
$150
million resulting primarily from the release of tax reserves and
valuation
allowances of which:
|
·
|
$88
million (of which $81 million is reported as a special item) is
reported
in the International segment, Other Operations and Corporate as
income
from continuing operations; and
|
·
|
$62
million relates to the divestiture of CIGNA's Brazilian health
care
business, which is included in income from discontinued
operations.
|
SPECIAL
ITEMS
(In
millions)
|
Pre-Tax
Benefit
(Charge)
|
|
After-Tax
Benefit
(Charge)
|
||||
Three
Months Ended September 30,
|
|
|
|
|
|
||
2005
|
|
|
|
|
|
||
Accelerated
amortization of deferred gain on sale of retirement benefits
business (see
page 25)
|
|
$
|
10
|
|
$
|
2
|
|
2004
|
|
|
|
|
|
|
|
Accelerated
amortization of deferred gain on sale of retirement benefits
business
|
|
$
|
122
|
|
$
|
79
|
|
Net
charge associated with a modified coinsurance arrangement
|
|
|
(14
|
)
|
|
(9
|
)
|
Total
|
|
$
|
108
|
|
$
|
70
|
|
Nine
Months Ended September 30,
|
|
|
|
|
|
|
|
2005
|
|
|
|
|
|
|
|
Accelerated
amortization of deferred gain on sale of retirement benefits
business (see
page 25)
|
|
$
|
315
|
|
$
|
200
|
|
IRS
tax settlement (see page 22)
|
|
|
83
|
|
|
81
|
|
Cost
reduction charge (see page 26)
|
|
|
(51
|
)
|
|
(33
|
)
|
Charge
associated with a modified coinsurance arrangement (see page
25)
|
|
|
(12
|
)
|
|
(8
|
)
|
Total
|
|
$
|
335
|
|
$
|
240
|
|
2004
|
|
|
|
|
|
|
|
Accelerated
amortization of deferred gain on sale of retirement benefits
business
|
|
$
|
122
|
|
$
|
79
|
|
Cost
reduction charge
|
|
|
(75
|
)
|
|
(49
|
)
|
Net
charge associated with a modified coinsurance arrangement
|
|
|
(14
|
)
|
|
(9
|
)
|
Effect
of new accounting pronouncement
|
(17
|
)
|
(11
|
)
|
|||
Total
|
$
|
16
|
$
|
10
|
·
|
lower
premiums and fees in the Health Care segment primarily due to lower
membership;
|
·
|
lower
gain amortization associated with the sale of the retirement benefits
business; and
|
·
|
losses
from futures contracts, compared to gains in the prior year, in
connection
with the program to reduce equity market risks (see guaranteed
minimum
death benefit contracts on page 34).
|
·
|
lower
realized gains and reduced net investment income associated with
the sale
of the retirement benefits business;
and
|
·
|
lower
premiums and fees in the Health Care segment primarily due to lower
membership.
|
·
|
additional
accelerated recognition of the deferred gain on the sale of the
retirement
benefits business; and
|
·
|
additional
amounts associated with a modified coinsurance arrangement (see
page 25).
|
·
|
it
requires assumptions to be made that were uncertain at the time
the
estimate was made; and
|
·
|
changes
in the estimate or different estimates that could have been selected
could
have a material impact on CIGNA’s consolidated results of operations or
financial condition.
|
·
|
future
policy benefits - guaranteed minimum death benefits;
|
·
|
Health
Care medical claims payable;
|
·
|
other
liabilities and other assets - guaranteed minimum income benefits;
|
·
|
reinsurance
recoverables for Run-off Reinsurance; and
|
·
|
investments
- recognition of losses from other-than-temporary impairments
of public
and private placement fixed
maturities.
|
(In
millions)
|
Pre-Tax
|
After-Tax
|
|||||
Three
Months Ended September 30,
|
|||||||
2005
|
|||||||
Accelerated
deferred gain amortization
|
$
|
10
|
$
|
2
|
|||
Normal
deferred gain amortization
|
$
|
3
|
$
|
2
|
|||
2004
|
|||||||
Accelerated
deferred gain amortization
|
$
|
122
|
$
|
79
|
|||
Normal
deferred gain amortization
|
$
|
28
|
$
|
18
|
|||
Nine
Months Ended September 30,
|
|||||||
2005
|
|||||||
Accelerated
deferred gain amortization
|
$
|
315
|
$
|
200
|
|||
Normal
deferred gain amortization
|
$
|
21
|
$
|
14
|
|||
2004
|
|||||||
Accelerated
deferred gain amortization
|
$
|
126
|
$
|
82
|
|||
Normal
deferred gain amortization
|
$
|
57
|
$
|
37
|
(In
millions)
|
Health
Care
|
|
Corporate
|
|
Total
|
|||||
First
quarter 2005 charge
|
$
|
22
|
$
|
29
|
$
|
51
|
||||
First
quarter 2005 payments
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
||||
Balance
as of March 31, 2005
|
21
|
27
|
48
|
|||||||
Second
quarter 2005 payments
|
(5
|
)
|
(6
|
)
|
(11
|
)
|
||||
Balance
as of June 30, 2005
|
16
|
21
|
37
|
|||||||
Third
quarter 2005 payments
|
(4
|
)
|
(5
|
)
|
(9
|
)
|
||||
Balance
as of September 30, 2005
|
$
|
12
|
$
|
16
|
$
|
28
|
(In
millions)
|
Health
Care/
Disability and
Life*
|
Corporate
|
Total
|
|||||||
Balance
as of December 31, 2004:
|
||||||||||
Severance
|
$
|
11
|
$
|
9
|
$
|
20
|
||||
Real
estate
|
8
|
1
|
9
|
|||||||
19
|
10
|
29
|
||||||||
First
quarter 2005 payments:
|
||||||||||
Severance
|
(6
|
)
|
(6
|
)
|
(12
|
)
|
||||
Real
estate
|
(1
|
)
|
—
|
(1
|
)
|
|||||
Balance
as of March 31, 2005
|
12
|
4
|
16
|
|||||||
Second
quarter 2005 payments:
|
||||||||||
Severance
|
(4
|
)
|
(2
|
)
|
(6
|
)
|
||||
Real
estate
|
(1
|
)
|
(1
|
)
|
(2
|
)
|
||||
Balance
as of June 30, 2005
|
7
|
1
|
8
|
|||||||
Third
quarter 2005 payments:
|
||||||||||
Severance
|
(1
|
)
|
—
|
(1
|
)
|
|||||
Real
estate
|
(1
|
)
|
—
|
(1
|
)
|
|||||
Balance
as of September 30, 2005
|
$
|
5
|
$
|
1
|
$
|
6
|
·
|
$105
million for minimum funding requirements for the domestic pension
plan and
for voluntary contributions to the international pension plans;
and
|
·
|
$440
million for voluntary contributions to the domestic pension plan,
which
represent an acceleration of expected payments for minimum funding
requirements in 2006 and 2007.
|
·
|
additional
mandated benefits or services that increase costs without improving
the
quality of care;
|
·
|
legislation
that would grant plan participants broader rights to sue their
health
plans;
|
·
|
changes
in ERISA regulations resulting in increased administrative burdens
and
costs;
|
·
|
additional
restrictions on the use of prescription drug formularies;
|
·
|
additional
privacy legislation and regulations that interfere with the proper
use of
medical information for research, coordination of medical care
and disease
and disability management;
|
·
|
additional
rules establishing the time periods for payment of health care
provider
claims that vary from state to state;
|
·
|
legislation
that would exempt independent physicians from antitrust laws;
and
|
·
|
changes
in federal laws, such as amendments to income tax laws, which could
affect
the taxation of employer provided benefits, and pension legislation,
which
could increase pension cost.
|
FINANCIAL
SUMMARY
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
2,513
|
$
|
2,779
|
$
|
7,556
|
$
|
8,259
|
|||||
Net
investment income
|
68
|
69
|
201
|
210
|
|||||||||
Other
revenues
|
270
|
259
|
796
|
766
|
|||||||||
Segment
revenues
|
2,851
|
3,107
|
8,553
|
9,235
|
|||||||||
Benefits
and expenses
|
2,598
|
2,788
|
7,746
|
8,415
|
|||||||||
Income
before taxes
|
253
|
319
|
807
|
820
|
|||||||||
Income
taxes
|
89
|
113
|
279
|
287
|
|||||||||
Segment
earnings
|
$
|
164
|
$
|
206
|
$
|
528
|
$
|
533
|
|||||
Realized
investment
gains,
net of taxes
|
$
|
3
|
$
|
5
|
$
|
6
|
$
|
9
|
|||||
Special
item (after-tax) included in
segment
earnings:
|
|||||||||||||
Cost
reduction charge
|
$
|
—
|
$
|
—
|
$
|
(14
|
)
|
$
|
(28
|
)
|
·
|
higher
earnings in the experience-rated business reflecting favorable
underwriting and medical management
results;
|
·
|
lower
operating expenses; and
|
·
|
strong
specialty health care results.
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In millions)
|
2005
|
2004
|
2005
|
|
2004
|
||||||||
Commercial
HMO
|
$
|
655
|
$
|
807
|
$
|
1,976
|
$
|
2,465
|
|||||
Experience-rated
medical
|
694
|
767
|
2,071
|
2,190
|
|||||||||
Dental
|
222
|
221
|
672
|
659
|
|||||||||
Medicare
and Medicaid
|
73
|
73
|
213
|
220
|
|||||||||
Other
medical
|
349
|
290
|
1,024
|
860
|
|||||||||
Life
and other non-medical
|
102
|
159
|
310
|
429
|
|||||||||
Total
premiums
|
2,095
|
2,317
|
6,266
|
6,823
|
|||||||||
Fees
|
418
|
462
|
1,290
|
1,436
|
|||||||||
Total
premiums and fees
|
$
|
2,513
|
$
|
2,779
|
$
|
7,556
|
$
|
8,259
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Medical
claims expense
|
$
|
1,579
|
$
|
1,671
|
$
|
4,633
|
$
|
5,044
|
|||||
Other
benefit expenses
|
85
|
141
|
276
|
425
|
|||||||||
Other
operating expenses
|
934
|
976
|
2,837
|
2,946
|
|||||||||
Total
benefits and expenses
|
$
|
2,598
|
$
|
2,788
|
$
|
7,746
|
$
|
8,415
|
(In thousands)
|
2005
|
2004
|
||||
Guaranteed
cost:
|
||||||
Commercial
HMO
|
801
|
1,003
|
||||
Medicare
and Medicaid
|
32
|
35
|
||||
Other
|
194
|
65
|
||||
Experience-rated1
|
1,155
|
1,275
|
||||
Service
|
6,884
|
7,535
|
||||
Total
medical membership
|
9,066
|
9,913
|
·
|
offering
products that meet emerging market and consumer
trends;
|
·
|
improving
medical membership results;
|
·
|
lowering
medical cost trends;
|
·
|
continuing
to deliver quality member service;
and
|
·
|
lowering
administrative expenses.
|
·
|
a
diverse product portfolio that meets emerging consumer-directed
trends;
|
·
|
consistent
and responsive member service
delivery;
|
·
|
competitive
provider networks; and
|
·
|
strong
clinical quality in medical, specialty health care and disability
management;
|
· | strengthen CIGNA's national provider network; |
·
|
enhance
CIGNA's ability to provide superior medical and
disease management programs;
|
·
|
provide
administrative ease for multi-state employers;
and
|
·
|
grow
membership in key geographies, as well as providing a basis for
lowering
medical costs.
|
FINANCIAL
SUMMARY
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
508
|
$
|
479
|
$
|
1,517
|
$
|
1,425
|
|||||
Net
investment income
|
67
|
62
|
199
|
186
|
|||||||||
Other
revenues
|
49
|
53
|
150
|
153
|
|||||||||
Segment
revenues
|
624
|
594
|
1,866
|
1,764
|
|||||||||
Benefits
and expenses
|
544
|
534
|
1,620
|
1,585
|
|||||||||
Income
before taxes
|
80
|
60
|
246
|
179
|
|||||||||
Income
taxes
|
23
|
19
|
71
|
51
|
|||||||||
Segment
earnings
|
$
|
57
|
$
|
41
|
$
|
175
|
$
|
128
|
|||||
Realized
investment gains,
net
of taxes
|
$
|
1
|
$
|
3
|
$
|
3
|
$
|
4
|
|||||
Special
item (after-tax) included in
segment
earnings:
|
|||||||||||||
Cost
reduction charge
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
(1
|
)
|
·
|
disability
insurance;
|
·
|
disability
and workers’ compensation case
management;
|
·
|
life
insurance; and
|
·
|
accident
and specialty association insurance.
|
·
|
favorable
mortality experience and lower expenses in the life insurance business;
|
·
|
improved
results in the accident and specialty businesses;
and
|
·
|
continued
solid disability earnings.
|
FINANCIAL
SUMMARY
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
316
|
$
|
254
|
$
|
923
|
$
|
745
|
|||||
Net
investment income
|
18
|
16
|
50
|
42
|
|||||||||
Other
revenues
|
—
|
(2
|
)
|
(3
|
)
|
3
|
|||||||
Segment
revenues
|
334
|
268
|
970
|
790
|
|||||||||
Benefits
and expenses
|
298
|
233
|
858
|
701
|
|||||||||
Income
before taxes
|
36
|
35
|
112
|
89
|
|||||||||
Income
taxes
|
12
|
12
|
26
|
31
|
|||||||||
Segment
earnings
|
$
|
24
|
$
|
23
|
$
|
86
|
$
|
58
|
|||||
Realized
investment gains,
net
of taxes
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
1
|
|||||
Special
item (after-tax) included
in
segment earnings:
|
|||||||||||||
IRS
tax settlement
|
$
|
—
|
$
|
—
|
$
|
7
|
$
|
—
|
·
|
new
sales growth and improved customer retention in the life, accident
and
health insurance operations, particularly in South Korea;
and
|
·
|
higher
premiums and fees for the expatriate employee benefits business
resulting
from membership growth.
|
FINANCIAL
SUMMARY
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
—
|
$
|
59
|
$
|
1
|
$
|
175
|
|||||
Net
investment income
|
34
|
53
|
106
|
424
|
|||||||||
Other
revenues
|
13
|
135
|
337
|
347
|
|||||||||
Segment
revenues
|
47
|
247
|
444
|
946
|
|||||||||
Benefits
and expenses
|
41
|
114
|
130
|
741
|
|||||||||
Income
before taxes
|
6
|
133
|
314
|
205
|
|||||||||
Income
taxes
|
4
|
43
|
114
|
59
|
|||||||||
Segment
earnings
|
$
|
2
|
$
|
90
|
$
|
200
|
$
|
146
|
|||||
Realized
investment gains,
net
of taxes
|
$
|
—
|
$
|
1
|
$
|
7
|
$
|
268
|
|||||
Special
items (after-tax) included in
segment
earnings:
|
|||||||||||||
Accelerated
recognition of
deferred
gain on sale of
retirement
benefits business
|
$
|
2
|
$
|
79
|
$
|
200
|
$
|
79
|
|||||
Net
charge associated with a
modified
coinsurance
arrangement
|
$
|
—
|
$
|
(9
|
)
|
$
|
(8
|
)
|
$
|
(9
|
)
|
||
Effect
of new accounting
pronouncement
(see
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
(11
|
)
|
·
|
gain
recognition related to the sale of the retirement benefits
business;
|
·
|
results
of modified coinsurance
arrangements;
|
·
|
expenses
associated with the run-off of this business;
and
|
·
|
results
of the retirement benefits business prior to the April 2004
sale.
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
||||||||||||
(In
millions, pre-tax)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Normal
deferred gain amortization
|
|
$
|
3
|
|
$
|
28
|
|
$
|
21
|
|
$
|
57
|
|
Accelerated
deferred gain amortization
|
|
$
|
10
|
|
$
|
122
|
|
$
|
315
|
|
$
|
126*
|
|
Changes
in fair value of securities supporting experience-rated
pension
policyholder contracts
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
165
|
FINANCIAL
SUMMARY
|
Three
Months
Ended
September
30,
|
Nine
Months
Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
20
|
$
|
16
|
$
|
65
|
$
|
56
|
|||||
Net
investment income
|
25
|
22
|
73
|
70
|
|||||||||
Other
revenues
|
(45
|
)
|
34
|
(28
|
)
|
(24
|
)
|
||||||
Segment
revenues
|
—
|
72
|
110
|
102
|
|||||||||
Benefits
and expenses
|
1
|
125
|
146
|
183
|
|||||||||
Loss
before income tax
benefits
|
(1
|
)
|
(53
|
)
|
(36
|
)
|
(81
|
)
|
|||||
Income
taxes (benefits)
|
2
|
1
|
(7
|
)
|
(4
|
)
|
|||||||
Segment
loss
|
$
|
(3
|
)
|
$
|
(54
|
)
|
$
|
(29
|
)
|
$
|
(77
|
)
|
|
Realized
investment gains,
net
of taxes
|
$
|
1
|
$
|
2
|
$
|
2
|
$
|
—
|
·
|
settlements
with reinsurers for amounts greater than the net recorded amount;
and
|
·
|
the
absence of a charge recorded in 2004 related to credit
risk.
|
FINANCIAL
SUMMARY
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Premiums
and fees
|
$
|
24
|
$
|
31
|
$
|
89
|
$
|
94
|
|||||
Net
investment income
|
110
|
114
|
336
|
358
|
|||||||||
Other
revenues
|
23
|
35
|
76
|
124
|
|||||||||
Segment
revenues
|
157
|
180
|
501
|
576
|
|||||||||
Benefits
and expenses
|
121
|
145
|
376
|
485
|
|||||||||
Income
before taxes
|
36
|
35
|
125
|
91
|
|||||||||
Income
taxes
|
11
|
12
|
30
|
32
|
|||||||||
Segment
earnings
|
$
|
25
|
$
|
23
|
$
|
95
|
$
|
59
|
|||||
Realized
investment gains
(losses),
net of taxes
|
$
|
1
|
$
|
(3
|
)
|
$
|
—
|
$
|
9
|
||||
Special
item (after-tax)
included
in segment
earnings:
|
|||||||||||||
IRS
tax settlement
|
$
|
—
|
$
|
—
|
$
|
11
|
$
|
—
|
·
|
gain
recognition related to the 1998 sale of the individual life insurance
and
annuity business;
|
·
|
corporate
life insurance (including policies on which loans are
outstanding);
|
·
|
settlement
annuity business; and
|
·
|
certain
investment management services (a significant portion of which
was sold
during the fourth quarter of 2004).
|
·
|
the
absence of severance and employee retention costs recorded in 2004
associated with the investment operations supporting the sold retirement
benefits business; and
|
·
|
higher
earnings in the corporate life insurance business primarily due
to
continued favorable mortality
experience.
|
FINANCIAL
SUMMARY
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||
(In
millions)
|
2005
|
|
2004
|
|
2005
|
|
2004
|
||||||
Segment
loss
|
$
|
(16
|
)
|
$
|
(29
|
)
|
$
|
(7
|
)
|
$
|
(119
|
)
|
|
Special
items (after-tax)
included
in segment loss:
|
|||||||||||||
IRS
tax settlement
|
$
|
—
|
$
|
—
|
$
|
63
|
$
|
—
|
|||||
Cost
reduction charge
|
$
|
—
|
$
|
—
|
$
|
(19
|
)
|
$
|
(20
|
)
|
·
|
lower
stock compensation expense due to fewer awards in 2005 and accelerated
vesting in 2004 and;
|
·
|
an
additional tax benefit of $7 million related to the completion
of a
federal tax audit.
|
·
|
overhead
costs included in 2004 associated with the sold retirement benefits
business; and
|
·
|
costs
recorded in 2004 associated with retiring $76 million of long-term
debt.
|
FINANCIAL
SUMMARY
(In millions)
|
Nine
Months
Ended
September
30,
2005
|
|||
Income
tax benefits:
|
||||
Property
and Casualty insurance business
|
$
|
287
|
||
Brazilian
Health Care operations
|
62
|
|||
Income
from discontinued operations
|
$
|
349
|
·
|
maintaining
appropriate levels of liquidity in its investment
portfolio;
|
·
|
using
cash flows from operating activities;
and
|
·
|
matching
investment maturities to the estimated duration of the related
insurance
and contractholder liabilities.
|
(In
millions)
|
2005
|
2004
|
|||||
Operating
activities
|
$
|
253
|
$
|
1,204
|
|||
Investing
activities
|
$
|
(277
|
)
|
$
|
1,657
|
||
Financing
activities
|
$
|
(1,246
|
)
|
$
|
(1,328
|
)
|
·
|
The
change in cash flows from operating activities was affected by
the
following significant items in 2005 and 2004:
|
§
|
2004
net proceeds from sales and maturities of securities supporting
experience-rated pension policyholder contracts of $1.0 billion.
Such
proceeds were used to fund most of the 2004 withdrawals from
contractholder deposit funds discussed below under
financing;
|
§
|
2005
voluntary pension contributions of $440 million; and
|
§
|
Lower
tax payments in 2005 compared with 2004 of $325 million, primarily
due to
the taxes paid in 2004 related to the sale of the retirement benefits
business.
|
·
|
Cash
used in investing activities primarily consisted of net purchases
of
investments ($227 million) and net purchases of property and equipment
($32 million).
|
·
|
Cash
used in financing activities primarily consisted of dividends on
and
repurchases of common stock ($1.0 billion), net withdrawals from
contractholder deposit funds ($284 million) and change in cash
overdraft
position ($219 million), partially offset by proceeds from issuances
of
common stock under CIGNA's stock plans ($301
million).
|
·
|
Cash
provided by investing activities primarily consisted of proceeds
from the
sale of the retirement benefits business of $2.1 billion, partially
offset
by net purchases of investments ($390 million) and property and
equipment
($32 million).
|
·
|
Cash
used in financing activities consisted primarily of repurchases
of and
payments of dividends on common stock ($580 million), net withdrawals
from
contractholder deposit funds ($673 million), repayment of debt
($76
million), and change in cash overdraft position ($23
million).
|
·
|
provide
capital necessary to support growth and maintain or improve the
financial
strength ratings of subsidiaries;
|
·
|
consider
acquisitions that are strategically and economically advantageous;
and
|
·
|
return
capital to investors through share
repurchase.
|
·
|
meet debt service requirements and pay dividends to CIGNA shareholders; and |
·
|
satisfy pension plan funding requirements. |
·
|
management
uses cash for investment opportunities;
|
·
|
a
substantial insurance or contractholder liability becomes due before
related investment assets mature;
|
·
|
a
substantial increase in funding is required for CIGNA's program
to reduce
the equity market risks associated with the guaranteed minimum
death
benefit contracts; or
|
·
|
regulatory
restrictions prevent the insurance and HMO subsidiaries from distributing
cash to the parent company.
|
CG
Life Insurance
Ratings
|
CIGNA
Corporation
Debt
Ratings
|
||
Senior
Debt
|
Commercial
Paper
|
||
A.M.
Best
|
A-
|
—
|
—
|
Moody’s
|
A3
|
Baa3
|
P3
|
S&P
|
A-
|
BBB
|
A2
|
Fitch
|
A
|
BBB
|
F2
|
·
|
No
annuitants surrendered their accounts;
and
|
·
|
All
annuitants lived to elect their benefits;
and
|
·
|
All
annuitants elected to receive their benefit on the first available
date
(2005 through 2014); and
|
·
|
All
underlying mutual fund investment values remained at the September
30,
2005 value of $3.3 billion, with no future
returns.
|
·
|
purchase
$91 million of fixed maturities;
|
·
|
extend
credit under commercial mortgage loans agreements of $360 million,
most of
which were at a fixed market rate of interest;
and
|
·
|
contribute
$350 million to real estate joint ventures and security
partnerships.
|
(In
millions)
|
September
30,
2005
|
December
31,
2004
|
Problem
bonds
|
$16
|
$37
|
Potential
problem bonds
|
$34
|
$44
|
Problem
mortgage loans
|
$10
|
$65
|
Potential
problem mortgage loans
|
$53
|
$72
|
Foreclosed
real estate
|
$11
|
$10
|
·
|
·
|
minimum
pension liabilities since equity securities comprise a significant
portion
of the assets of CIGNA’s employee pension plans.
|
1.
|
increased
medical costs that are higher than anticipated in establishing
premium
rates in CIGNA’s health care operations, including increased use and costs
of medical services;
|
2.
|
increased
medical, administrative, technology or other costs resulting from
new
legislative and regulatory requirements imposed on CIGNA’s employee
benefits businesses (see Employee benefits regulation on page 27 for more information);
|
3.
|
challenges
and risks associated with implementing the improvement initiatives
in the
health care operations, the organizational realignment and the
reduction
of overall CIGNA and health care cost structure, including that
operational efficiencies and medical cost benefits do not emerge
as
expected and that membership does not stabilize and begin to grow,
resulting in significantly greater than expected reductions in
medical
membership;
|
4.
|
risks
associated with the amount and timing of gain recognition on the
sale of
CIGNA's retirement benefits
business;
|
5.
|
risks
associated with pending and potential state and federal class action
lawsuits, purported securities class action lawsuits, disputes
regarding
reinsurance arrangements, other litigation and regulatory actions
challenging CIGNA’s businesses and the outcome of pending government
proceedings;
|
6.
|
heightened
competition, particularly price competition, which could reduce
product
margins and constrain growth in CIGNA’s businesses, primarily
the health care business;
|
7.
|
significant
changes in interest rates;
|
8.
|
downgrades
in the financial strength ratings of CIGNA’s insurance subsidiaries, which
could, among other things, adversely affect new sales and retention
of
current business;
|
9.
|
limitations
on the ability of CIGNA's insurance subsidiaries to dividend capital
to
the parent company as a result of downgrades in the subsidiaries’
financial strength ratings, changes in statutory reserve or capital
requirements or other financial
constraints;
|
10.
|
inability
of the program adopted by CIGNA to substantially reduce equity
market
risks for reinsurance contracts that guarantee minimum death benefits
under certain variable annuities (including possible market difficulties
in entering into appropriate futures and forward contracts and
in matching
such contracts to the underlying equity risk);
|
11.
|
adjustments
to the reserve assumptions and other considerations (including
lapse,
partial surrender, mortality, interest rates and volatility) used
in
estimating CIGNA's liabilities for reinsurance contracts that guarantee
minimum death benefits under certain variable annuities;
|
12.
|
adjustments
to the assumptions (including annuity election rates and reinsurance
recoverables) used in estimating CIGNA’s assets and liabilities for
reinsurance contracts that guarantee minimum income benefits under
certain
variable annuities;
|
13.
|
significant
stock market declines, which could, among other things, result
in
increased pension expenses in CIGNA’s pension plan in future periods and
the recognition of additional pension obligations;
|
14.
|
unfavorable
claims experience related to workers’ compensation and personal accident
exposures of the run-off reinsurance business, including losses
attributable to the inability to recover claims from
retrocessionaires;
|
15.
|
significant
deterioration in economic conditions, which could have an adverse
effect
on CIGNA’s operations and investments;
|
16.
|
changes
in federal laws, such as amendments to income tax laws, which could
affect
the taxation of employer provided benefits, and pension legislation,
which
could increase pension cost;
|
17.
|
potential
public health epidemics and bio-terrorist activity, which could,
among
other things, cause our covered medical expenses and mortality
experience to rise significantly, depending on the severity of the
event and number of individuals affected who are covered under
CIGNA’s
insurance products;
|
18.
|
risks
associated with security or interruption of information systems,
which could among other things cause operational
disruption; and
|
19.
|
risk
factors detailed in CIGNA's Form 10-K for the fiscal year ended
December
31, 2004, including the Cautionary Statement in Management's Discussion
and Analysis.
|
Quantitative
and Qualitative Disclosures About Market
Risk
|
Controls
and Procedures
|
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
||
(c)
|
Purchases
of Equity Securities by the Issuer and Affiliated
Purchasers
|
Issuer
Purchases of Equity Securities
|
|||||||||||||
Period
|
Total
# of
shares
purchased
(1)
|
Average
price
paid
per share
|
|
Total
# of shares
purchased
as part of
publicly
announced
program
(2)
|
Approximate
dollar
value
of
shares
that may yet be
purchased
as part of publicly
announced
program (3)
|
||||||||
July
1-31, 2005
|
594,883
|
|
$108.74
|
589,600
|
$227,111,373
|
||||||||
August
1-31, 2005
|
1,485,933
|
|
$113.28
|
1,479,500
|
$559,519,832
|
||||||||
September
1-30, 2005
|
2,036,322
|
|
$114.69
|
2,031,400
|
$326,382,998
|
||||||||
Total
|
4,117,138
|
|
$113.32
|
4,100,500
|
N/A
|
Includes
shares tendered by employees as payment of taxes withheld on the
exercise
of stock options and the vesting of restricted stock granted under
the
Company’s equity compensation plans. Employees tendered 5,283 shares in
July, 6,433 shares in August, and 4,922 shares in September.
|
|
(2)
|
CIGNA
has had a repurchase program for many years, and has had varying
levels of
repurchase authority and activity under this program. The program
has no
expiration date. CIGNA suspends activity under this program from
time to
time, generally without public announcement. Remaining authorization
under
the program was approximately $326 million as of September 30, 2005
and
$698 million as of November 2, 2005.
|
(3)
|
Approximate
dollar value of shares is as of the last date of the applicable
month.
|
Exhibits
|
(a)
|
See
Exhibit
Index.
|
CIGNA
CORPORATION
|
||
By:
|
/s/
Michael W. Bell
|
|
|
Michael
W. Bell
|
|
|
Executive
Vice President and
|
|
|
Chief
Financial Officer
|
Number
|
Description
|
Method
of Filing
|
Computation
of Ratio of Earnings
|
Filed
herewith.
|
|
to
Fixed Charges
|
||
Certification
of Chief Executive Officer
|
Filed
herewith.
|
|
of
CIGNA Corporation pursuant to
|
||
Rule
13a-14(a) or Rule 15d-14(a)
|
||
of
the Securities Exchange Act of 1934
|
||
Certification
of Chief Financial Officer
|
Filed
herewith.
|
|
of
CIGNA Corporation pursuant to
|
||
Rule
13a-14(a) or Rule 15d-14(a)
|
||
of
the Securities Exchange Act of 1934
|
||
Certification
of Chief Executive Officer
|
Furnished
herewith.
|
|
of
CIGNA Corporation pursuant to Rule
|
||
13a-14(b)
or Rule 15d-14(b) and 18
|
||
U.S.C.
Section 1350
|
||
Certification
of Chief Financial Officer
|
Furnished
herewith.
|
|
of
CIGNA Corporation pursuant to Rule
|
||
13a-14(b)
or Rule 15d-14(b) and 18
|
||
U.S.C.
Section 1350
|